AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

Blood Test Could Predict Parkinson's Seven Years Before Symptoms June 18, 2024 — Scientists have developed a simple blood test that uses artificial intelligence (AI) to predict Parkinson's up to ...

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) ...

Elliot Lee says the carrot of playing at Wembley will ensure Wrexham field a strong side when they travel to Port Vale in the ...

Among participants who did not have Parkinson’s, the test showed the absence of the disease 96% of the time. Crucially, the study also revealed that 86% of prodromal or pre-symptomatic cases of ...